Lutein and Zeaxanthin: The Macula's Protective Pigments

At the very centre of your retina lies a small area called the macula, responsible for reading, recognising faces and seeing fine detail. Look at it through a microscope and you will notice something unusual: it is yellow. That colour comes from two plant pigments, lutein and zeaxanthin, which your body cannot make and must obtain from food. They accumulate in the macula at concentrations far higher than anywhere else in the body.

Over the past few decades, lutein and zeaxanthin have moved from obscure biochemistry to supplement shelves around the world. This article explains what these carotenoids actually do, which foods provide them, what the large AREDS2 trial found, and how to think sensibly about supplements, without the marketing hype.

What are lutein and zeaxanthin?

Lutein and zeaxanthin belong to the carotenoid family, the same group of natural pigments that gives carrots, tomatoes and autumn leaves their colours. Unlike beta-carotene, they are not converted into vitamin A. Instead, they belong to a subgroup called xanthophylls, which contain oxygen and have a yellow colour. A third closely related compound, meso-zeaxanthin, is found in the macula too; most of it is thought to be formed in the eye from lutein.

Because these molecules are fat-soluble, they travel in the blood bound to lipoproteins and are absorbed best when eaten with some fat. Specific binding proteins in the retina capture them and concentrate them in the macula, particularly in the nerve fibre layers in front of the cone photoreceptors. Zeaxanthin and meso-zeaxanthin dominate at the very centre (fovea), while lutein is relatively more abundant further out.

The role of macular pigment

A natural blue-light filter

Macular pigment absorbs light in the blue part of the spectrum, peaking at around 460 nanometres. Because it sits in front of the photoreceptors, it acts like a built-in pair of yellow-tinted filters, reducing the amount of high-energy blue light reaching the most delicate cells. Blue light is scattered more than other wavelengths, so filtering it may also slightly improve contrast and reduce glare, although the practical size of these visual benefits is still debated.

It is worth separating this from screen marketing. The blue light from phones and computers is far weaker than daylight, and current evidence does not show that it damages the retina. For a balanced discussion, see our article on blue light facts and marketing.

Antioxidant protection

The retina is a hostile environment for cells: it is exposed to light, uses large amounts of oxygen and contains polyunsaturated fats easily damaged by oxidation. Lutein and zeaxanthin can neutralise reactive oxygen molecules and help protect cell membranes. Oxidative stress is thought to contribute to age-related macular degeneration (AMD), which is one reason researchers became interested in these pigments.

Measuring macular pigment

Macular pigment optical density (MPOD) can be measured with specialised instruments, mostly in research settings. Levels vary widely between individuals. Lower levels have been associated with older age, smoking, obesity, low intake of vegetables and, in some studies, with AMD. Supplementation can raise MPOD over months, but whether raising it translates into fewer cases of disease in healthy people has not been proven.

Food sources of lutein and zeaxanthin

Dark green leafy vegetables are the richest sources by far. Eggs contain smaller amounts, but the fat in the yolk makes their pigments highly bioavailable. Yellow and orange produce contributes zeaxanthin in particular. The table below gives a qualitative guide; exact amounts vary with variety, season and preparation.

Typical Western diets provide only a few milligrams per day, and many people eat far less than the amounts found in diets rich in vegetables. Increasing leafy greens a few times a week can substantially raise intake. For more food ideas, see our list of 15 foods that support eye health.

What AREDS2 found

The first Age-Related Eye Disease Study (AREDS), published in 2001 by the US National Eye Institute, showed that a high-dose combination of vitamin C, vitamin E, beta-carotene, zinc and copper reduced the risk of progressing to advanced AMD by about 25 percent over five years in people who already had intermediate AMD or advanced AMD in one eye. Beta-carotene, however, had been linked to an increased lung cancer risk in smokers in other trials.

AREDS2, published in 2013, tested whether adding lutein (10 mg) and zeaxanthin (2 mg), omega-3 fatty acids, or both would improve the formula, and whether beta-carotene could be removed or replaced. The key findings were:

• Adding omega-3 fatty acids did not provide additional benefit.
• Adding lutein and zeaxanthin to the original formula did not produce a significant further benefit in the primary analysis overall.
• Participants with the lowest dietary intake of lutein and zeaxanthin appeared to benefit most from supplementation.
• In secondary analyses comparing lutein and zeaxanthin directly with beta-carotene, the lutein-zeaxanthin version was associated with a lower risk of progression to advanced AMD, particularly neovascular (wet) AMD.
• Former smokers taking beta-carotene had a higher rate of lung cancer, while those taking lutein and zeaxanthin did not.

As a result, the recommended AREDS2 formula replaced beta-carotene with lutein and zeaxanthin. A 10-year follow-up report published in 2022 supported this choice, finding that the lutein-zeaxanthin version continued to perform at least as well as or better than beta-carotene for slowing progression. Our article on AREDS supplements explains who qualifies.

Lutein, zeaxanthin and cataract

Lutein and zeaxanthin are also present in the lens. Observational studies have found that people with higher dietary intake tend to have a somewhat lower risk of cataract. In AREDS2, lutein and zeaxanthin supplementation did not significantly reduce the overall need for cataract surgery, although people with the lowest dietary intake may have benefited slightly. For cataract, the strongest protective measures remain not smoking, UV protection and managing conditions such as diabetes. Read more in our cataract guide.

Supplement considerations

Who might consider them

• People diagnosed with intermediate AMD, or advanced AMD in one eye, as part of the AREDS2 formula on the advice of an eye doctor.
• People with very low intake of leafy vegetables who cannot change their diet, after discussing it with a doctor; evidence of benefit here is less certain.

Who probably does not need them

Healthy people with no signs of AMD who eat a varied diet are unlikely to gain proven benefit from supplements. Early AMD (only small or few medium drusen) was not shown to benefit from the AREDS formula either.

Safety

Lutein and zeaxanthin are generally considered safe at the doses used in research. The most common side effect of very high intake is harmless yellowing of the skin (carotenodermia). A few case reports describe crystal deposits in the retina with very high long-term doses, but these are rare. Because supplement quality varies, choose a reputable brand and tell your doctor about everything you take. Pregnant or breastfeeding women and people with medical conditions should ask a professional first.

Beware of exaggerated claims

Lutein products are often marketed as improving eyesight, curing tired eyes or protecting against screens. There is no good evidence that they improve refractive errors, reverse existing vision loss or prevent digital eye strain. If your eyes feel tired from screen work, practical measures such as regular breaks and the 20-20-20 rule are more useful.

A practical approach

1. Eat dark leafy greens several times a week, cooked or raw with a little healthy fat.
2. Include eggs, sweetcorn, peas and orange or yellow vegetables in your weekly meals.
3. Avoid smoking, which lowers macular pigment and greatly increases AMD risk.
4. Have regular eye examinations, especially after 50 or if AMD runs in your family.
5. Discuss AREDS2 supplements with your eye doctor only if you are diagnosed with intermediate or advanced AMD.

To check your central vision between visits, our Amsler grid test is a simple screening aid, though it does not replace a professional examination. Learn more about the condition itself in our macular degeneration guide.

When to see a doctor

Book a routine eye examination if you notice gradual difficulty reading, a need for brighter light, reduced contrast or slower adaptation to darkness, particularly if you are over 50.